
A study by Eleven Biotherapeutics to prove the clinical value of its eye drug isunakinra has flopped, after the drug …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

